|
Speakers  | Alan Cass
Alan Cass is a Senior Director at The George Institute for International Health and Professor in Medicine at Sydney University. Alan trained as a renal physician and is employed full-time in clinical, population and health services research. He is the Chair of the Scientific Committee of the Australasian Kidney Trials Network.
|
 | Emma Duncan
Dr Emma Duncan is a Staff Specialist in Endocrinology at Princess Alexandra Hospital, Brisbane; Senior Lecturer at the University of Queensland; and Postdoctoral Research Fellow at the UQ Diamantina Institute of Cancer, Immunology and Metabolic Medicine.
She graduated in Medicine from the University of Sydney (with first class honours) in 1992 and moved to the UK in 1994. She undertook her doctoral studies into the genetics of osteoporosis at the Wellcome Trust Centre for Human Genetics, University of Oxford. She also completed both MRCP (UK) and FRACP, with advanced training in Endocrinology. She was appointed locum consultant in Endocrinology at the Oxford Centre for Diabetes, Endocrinology and Metabolism in 2004 before returning to Australia in 2005 to take up her current positions.
Dr Duncan’s main basic research interest remains the genetic control of bone mass. Current projects include genome-wide association studies of the control of bone mass and the genetic causes of high bone mass syndromes. She is also active in clinical bone research
|  | Terry Diamond |  | David Handelsman
Professor David Handelsman is Australia’s first professor of Andrology (Univ of Syd, 1996-), Head of the first Andrology Department (Concord Hospital, 1999-) and inaugural Professor/Director, ANZAC Research Institute (1998-). After training in medicine (FRACP Endocrinology) and research (NHMRC & Wellcome Research Fellow) he worked in USA and Germany and served many research and health policy bodies. He was awarded the RACP’s Susman Prize (1994), the inaugural AMA Men’s Health Award (2003) and Honorary Life Member, Endocrine Society of Australia (2008). Over 30 years, he has published over 350 scientific papers, served 12 Editorial Boards and been peer reviewer for over 100 scientific journals, supervised or co-supervised 21 PhD students and 11 other graduate students while maintaining continuous peer-reviewed and industry grant funding. His expertise in male reproductive health, medicine and biology has involved research in basic, clinical, translational and public health domains. His recent research interests focus on physiology and pharmacology of androgens, including genetic mouse models of androgen action, hormonal regulation of the testis and prostate and clinical applications and pharmacogenetics of androgens in sports doping detection, hormonal male contraception, male ageing, chronic medical disorders and prostate disease.
|  | Aidan McElduff
Dr McElduff is a clinical associate Professor at Sydney University. He is a part-time senior staff specialist in the Department of Endocrinology at Royal North Shore Hospital and in part-time private practice in the Northern Sydney Endocrine Centre. He has a long-standing interest in diabetes and the endocrine disorders of pregnancy. |
 | Shaun McGrath
Dr McGrath graduated UNSW 1992 with honours and completed Advanced training in Endocrinology in 2000 after training in Newcastle and London. After completing 3 years research in the Mothers and Babies Research Centre Newcastle he moved into private practice as Visiting Medical Officer, Department of Endocrinology John Hunter Hospital 2002. Dr McGrath has a large clinical practice in general endocrinology and began neck ultrasound in 2004. He continues to improve his skills in neck ultrasound with its developing role in the management of patients with thyroid nodules, preoperative lymph node mapping in those patients with known thyroid cancer, post operative surveillance of those patients with thyroid cancer and preoperative localisation of parathyroid adenomas for successful minimally invasive parathyroid surgery. He runs a regular integrated thyroid biopsy clinic with cytopathology and currently follows a cohort of over 150 patients with thyroid cancer. |  | Craig Munns
Craig Munns is the Senior Staff Specialist in Bone and Mineral Medicine and a Paediatric Endocrinologist at the Children’s Hospital at Westmead, Sydney, Australia and Senior Lecturer at The University of Sydney. Dr Munns has PhD through the University of Queensland, and trained in the diagnosis and management of paediatric bone and mineral disorders at the Shriners Hospital, Montreal, Canada. His research focus is genetic bone disorders and secondary osteoporosis. |  | George Muscat
George Muscat is a Professorial Research Fellow at the Institute for Molecular Bioscience, The University of Queensland, an affiliate of the School of Biomedical Sciences, and an NHMRC Principal Research Fellow. He completed his undergraduate (BSc, Hons, 1980) and graduate training (PhD, 1987) at the University of Sydney. He was a Postdoctoral Research Fellow at Stanford University, CA. (1985-88), and an Assistant Professor of Research at the University of Southern California, Los Angeles (1989). He joined UQ in 1990. He is a member of the editorial boards of Endocrinology, and Molecular Endocrinology. His research focuses on understanding the molecular role of Nuclear Hormone Receptors (NRs) in the regulation of metabolism and body composition in transgenic mouse models to gain insights into obesity, and type II diabetes. More recently, these insights are being applied to understanding the molecular basis of childhood obesity in collaboration with Dr Gary Leong. |  | Jonathan Silberberg
Jonathan Silberberg is a practicing cardiologist and Associate Professor of Medicine at the University of Newcastle. He graduated MBBCh at Witwatersrand (South Africa) in 1978, FRACP in 1986, MSc in Epidemiology at McGill (Canada) 1989 and PhD in Medicine at Newcastle in 1998. From 2003 to present he has represented cardiology and clinical epidemiology on the written exam committee of the RACP. |  | Duncan Topliss
Duncan Topliss is Director of the Department of Endocrinology and Diabetes at the Alfred Hospital, Melbourne, and an adjunct Professor of Medicine in the Department of Medicine, Monash University.
He is a past President and a Life Member of the Endocrine Society of Australia.He is a member of the editorial board of Clinical Endocrinology and a frequent reviewer for Clinical Endocrinology, Thyroid, and other endocrine journals. He has a long-standing interest in thyroidology with an MD thesis in this area and over 150 publications many on thyroid physiology and disease. He has a substantial experience in the management of thyroid disease and thyroid cancer over more than 30 years.He has a wide interest in clinical endocrinology including osteoporosis, pituitary and adrenal disease, and endocrine hypertension.
His other interest is drug regulation and safety: he is a member of the Commonwealth Government Advisory Committee on the Safety of Medicines and the Advisory Committee on Prescription Medicines.
|  | Stephen Twigg
Associate Professor Stephen Twigg graduated in Medicine with first class honours from the University of Sydney in 1988. After undertaking medical specialist training in Endocrinology at Royal North Shore Hospital, Sydney, he then completed a PhD studying growth factors in 1998 at the Kolling Institute of Medical Research, RNSH. In 1999, he commenced a NHMRC sponsored CJ Martin Postdoctoral Fellowship at Oregon Health Sciences University, USA, studying the role of growth factors in diabetes complications. At that site he also attended clinics managing children and adolescents who had diabetes. Following his return in 2001, he held a Senior Lecturer position in the Discipline of Medicine, The University of Sydney, being promoted to Associate Professor in 2006, and in 2003 he commenced as a senior staff endocrinologist at the Diabetes Centre and Dept of Endocrinology, Royal Prince Alfred Hospital in Sydney.
Steve’s main research focus is in diabetes complications, in particular the role played by blood glucose and growth factors in the development of diabetes complications, and in regulating these factors to improve clinical outcomes. He has obtained competitive basic and clinical research funding from NHMRC, Diabetes Australia Research Trust, and Juvenile Diabetes Research Foundation International. He provides leadership to the diabetes community and profession in his service functions as President of the Australian Diabetes Society, an honorary Board Member of Diabetes Australia Ltd, , and as a member of the Specialist Advisory Committee in Endocrinology of the Royal Australasian College of Physicians.
|  | Garry Warne
Professor Garry Warne is a consultant endocrinologist at the Royal Children’s Hospital, Melbourne and Director of Royal Children’s Hospital International, a department with major education and training projects in Vietnam. His original training was in adult endocrinology at the Royal Melbourne Hospital, after which he saw the light and switched to paediatric endocrinology, becoming a junior resident at the Royal Children’s Hospital Melbourne and then a Fellow at the Health Sciences Centre at the University of Manitoba, Canada. He rejoined the staff of RCHM in 1977 and was head of Endocrinology from 1980-99. His long term research interest has been to do with disorders of sex development (DSD) but in addition to that, he has pioneered the establishment of patient and parent support groups, written educational booklets for patients that have been translated into many languages, participated in the ethical debate about clinical management issues and supported the development of paediatric endocrinology as a specialty in a number of Asian countries. More recently he has become involved in the management of young people with Gender Identity Disorder (GID) and in the development of multi-disciplinary services for GID in Victoria. He has been awarded the Royal Children’s Hospital Gold Medal, the Victorian Health Minister’s Award for Outstanding Individual Achievement, the Vietnamese Ministry of Health’s medal “For the People’s Health”, The APEG Norman Wettenhall Medal for Research and Innovation, and in 2010 he was made a Member of the Order of Australia.
|  | John Wass
John Wass is the Professor of Endocrinology at Oxford University and Head of the Department of Endocrinology at the Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital Oxford, UK. He qualified at Guy’s in 1971 and did his endocrine training at Bart’s. He got his MD from the University of London in 1980. From 1989 he was Professor of Clinical Endocrinology and Sub-Dean, University of London at Bart’s.
His research interests include pituitary tumours, acromegaly, growth hormone deficiency, angiogenesis in endocrinology, and the genetics of osteoporosis and thyroid disease.
He has published over 330 articles in scientific journals and as well as written many reviews and chapters in textbooks including the Oxford Textbook of Medicine and DeGroot’s Textbook of Endocrinology. He has edited a number of different textbooks including the Oxford Textbook of Endocrinology and the Oxford Handbook of Endocrinology. He was editor of Clinical Endocrinology and is on the Editorial Board of numerous journals including Pituitary, the Journal of Clinical Endocrinology and Metabolism and Endocrine Reviews. He was President of the European Federation of Endocrine Societies from 2001-2203 and is Chairman of the Society for Endocrinology. He chaired the Programme Organising Committee for the International Endocrine Meeting in Rio de Janeiro in 2008.
|  | Jeffrey Zajac
Professor Jeffrey Zajac took up the position of Professor and Head of University of Melbourne, Department of Medicine at Austin Health in October 2000. He is a Clinical Endocrinologist and General Physician with research interests in molecular endocrinology. He is Chairman of the Division of Medicine and Director of the Department of Endocrinology at Austin Health.
He trained in Medicine at the University of Melbourne and undertook a PhD in the Department of Medicine, Austin & Repatriation Medical Centre. Following post doctoral work in the Endocrine Genetics Unit at Massachusetts General Hospital, Boston, USA, as an NIH Fogarty International Fellow, he was recruited to the Department of Medicine, Royal Melbourne Hospital, where he developed a Molecular Endocrinology research group. Fields of research include the aetiology and pathogenesis of type 2 diabetes, metabolic bone disease, testosterone and prostate cancer.
His research group has embarked on a major research program investigating the effect of androgen deprivation therapy in patients with prostate cancer. These investigations include effects on bone, muscle, cardiovascular risk and metabolic state.
Professor Zajac recently spent 6 months in the Department of Genetics and Development, Columbia University Medical Center, New York on sabbatical in the laboratory of Gerard Karsenty. Work from the laboratory is the subject of his presentation.
|
|
Speakers